|Articles|April 10, 1996
TechneScan sales to start in Sweden
Radiopharmaceutical developer Mallinckrodt Medical said that itwill begin sales in Sweden of TechneScan Q12, a technetium-basedcardiac imaging agent, following approval of the agent by Sweden'shealth authorities. Sweden is the first country in the
Advertisement
Radiopharmaceutical developer Mallinckrodt Medical said that it
will begin sales in Sweden of TechneScan Q12, a technetium-based
cardiac imaging agent, following approval of the agent by Sweden's
health authorities. Sweden is the first country in the European
Union to approve TechneScan, and certifications in other European
nations are expected. St. Louis-based Mallinckrodt filed a new
drug application for the product in the U.S. in 1994.
Advertisement
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Molecular Imaging in Focus: SNMMI: Can a New Total Body PET Scanner Slash Scan Times and Bolster Sensitivity?
2
PSMA PET Plays Key Role in Multinational Phase 3 Trial of Perioperative Apalutamide for PCa
3
Radiology Roundup of FDA News: June 1 — June 7
4
Molecular Imaging in Focus: PSMA PET Radiotracers and Urinary Radioactivity: What Head-to-Head Prospective Multicenter Research Reveals
5












